Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Hematology. American Society of Hematology. Education Program|December 10, 2021
Advances in the management of α-thalassemia major: reasons to be optimisticPaulina Horvei, Tippi MacKenzie, Sandhya KharbandaTransfusion|December 29, 2023
Effective peripheral blood stem cell collection in a 4.6-kg childJennifer M Jones, Joseph E Kiss, Irina Chibisov, et al.Annals of the Rheumatic Diseases|June 17, 2026
Autologous stem cell transplantation (ASCT) for Refractory juvenile-onset systemic sclerosis (JSSc)Kathryn S Torok, Paulina Horvei, Jonathan Li, et al.Expert Review of Clinical Immunology|March 8, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patientsIvan Foeldvari, Kathryn S Torok, Juliana Silva, et al.Leukemia|April 20, 2022
GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activityMichelle J Cox, Claudia Manriquez Roman, Erin E Tapper, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 3, 2021
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemiaMichelle J Cox, Fabrice Lucien, Reona Sakemura, et al.Blood|January 28, 2022
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myelomaReona Sakemura, Mehrdad Hefazi, Elizabeth L Siegler, et al.Cancer Immunology Research|July 10, 2021
Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and ToxicityReona Sakemura, Aditya Bansal, Elizabeth L Siegler, et al.Blood|October 25, 2023
CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRSR Leo Sakemura, Claudia Manriquez Roman, Paulina Horvei, et al.Cancer Immunology Research|June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T CellsR Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.Pageof 1